Obesity + Diabetes Mellitus
Integrated clinical research for adults with both obesity and diabetes—delivering new therapies and close monitoring for better health outcomes.
Obesity + Diabetes Mellitus Study
Focuses on addressing the combined challenges of obesity and diabetes. This study tests new therapies and care approaches to improve blood sugar control, support weight loss, and reduce the risk of future complications for patients with both conditions.
1. Blood Sugar & Metabolic Monitoring
Tracks HbA1c, fasting blood glucose, and insulin levels for diabetes management.
Evaluates cholesterol, triglycerides, and other key metabolic indicators.
2. Body Weight and Fat Distribution Assessment
Measures overall weight, BMI, and body fat percentage.
Monitors changes in body composition and weight loss during treatment.
3. Symptom and Daily Function Evaluation
Assesses fatigue, increased thirst, frequent urination, and other diabetes/obesity symptoms.
Tracks improvements in everyday wellbeing and activity levels.
4. Clinical Therapy and Medication Trials
Provides access to innovative medications, insulin regimens, and lifestyle intervention programs.
Medical experts monitor progress, safety, and therapy effectiveness throughout the study.
Eligible Participants Are
18 to 75 years of age
Diagnosed with Type 2 diabetes and obesity (BMI 30 or higher)
Currently managing diabetes with or without medication
Experiencing difficulty with blood sugar control and/or weight management
Willing to undergo regular blood tests and body composition assessments
Additional criteria apply
Eligible Participants May
Receive study-related medical care and treatment at no cost
Receive compensation for study-related time and travel
Gain access to investigational therapies and weight management programs
Contribute to advancing treatment for obesity and diabetes
The Obesity + Diabetes Mellitus Clinical Trial advances the development of treatments and care models for patients with both obesity and diabetes. Participation helps researchers improve future therapies and reduce the impact of these widespread conditions on global health.